In May, Medcrypt CEO Mike Kijewski was invited to the White House to discuss the critical issue of healthcare cybersecurity. Mike met with representatives from the NSC, CISA, HHS, DHS, and other key government agencies. Read more: https://t.co/xyc3NRwpah

With Medcrypt's Helm, medical device manufacturers can stay ahead of potential threats and ensure the safety of their devices. Read the full case study to learn how Helm is setting the standard for SBOM and Vulnerability Management: https://t.co/DDTp0GRfFf

Learn why things can't go back to "business as usual" after the Change Healthcare attack in this piece from @mikekijewski in @ForbesTechCncl: https://t.co/Xuweij3Pfl #cybersecurity #medtech #medicaldevicecybersecurity #changehealthcare

On April 18, 2024, MedISAO @isao_med and the @US_FDA signed a renewed MOU, reinforcing their ongoing collaboration and emphasizing the critical need to strengthen the #cybersecurity posture of the medical device industry. Read the full announcement: https://t.co/YOg5mDRbxU

Join us on May 22nd for an exclusive Medical Device Manufacturers Association @medicaldevices member-only webinar, "Ways to Succeed with the FDA Cybersecurity Guidance" Don't miss this opportunity. MDMA members can register now: https://t.co/NotmCuKpfT

Medcrypt is a proud participant in the Microsoft Copilot for Security Partner Private Preview. We're working with Microsoft product teams to help shape Copilot for Security product development. Read more: https://t.co/O7WICSVEll @MSFTCopilot #microsoftcopilot

Cybersecurity has quickly become more than a mere necessity; it is both a business imperative and a competitive advantage. Read about how to manage your #cybersecurity so it doesn't manage you from @mikekijewski in @ForbesTechCncl

The webinar recording for Medcrypt's webinar, Vulnerability Lifecycle Management: Check Yourself Before You Wreck Yourself, is now available: https://t.co/Do6Czw6HOW

Next Thursday at 11 AM PST, tune in as our VP of Services Naomi Schwartz discusses how the FDA conducts their reviews and what medical device manufacturers can do to respond to deficiency letters and achieve FDA approval. Register for free: https://t.co/iX0vAsde2f

Great B2B companies feel less like they're selling a product and more like they're evangelizing a movement. 5 principles for crafting a movement-defining strategic narrative, w/detailed examples from Gong, OneTrust, Salesforce, and others:

Medcrypt is excited to announce the addition of Taylor Lehmann to our Board of Directors! Taylor will play a pivotal role in supporting Medcrypt’s governance efforts, strategic initiatives, and championing investor interests. Read the full press release: https://t.co/7Zm50y9NI8

In the 4th installment of our FDA Readiness Blog Series, we go into detail on how Medcrypt, with its team of FDA and medical device experts, can help guide you through the submission process seamlessly. Read the full blog:

Medcrypt was recently listed in Black Book Market Research LLC's top 50 emerging health IT vendors. The series of surveys presented 925 vendor solutions to be scored on 18 start-up-specific key performance indicators. View Black Book's complete list:

What do medical device manufacturers need to understand about the FDA's new guidance? Hear from Medcrypt CEO Mike Kijewski and FDA experts Naomi Schwartz and Seth Carmody as they discuss what this means for MDMs in a new Medcrypt webinar. Register here: https://t.co/LjFTSVTtHc

On September 26th, 2023, the FDA issued an updated final guidance document for premarket medical device submissions. Medcrypt CEO Mike Kijewski shares his thoughts on the new guidance in a new blog post:

In the second installation of Medcrypt's FDA Guidance Readiness blog series, we explain the FDA's newly-announced Electronic Submission Template and Resource (eSTAR) mechanism and its importance to Medical Device Manufacturers (MDMs). Link to the blog: https://t.co/SLg4peg3fZ

The FDA ‘Cybersecurity Refuse to Accept Policy’ (RTA) will affect Medical Device Manufacturers! Webinar by @MedCrypt on Thursday, September 14th at 1 PM ET. Join the free webinar to hear from MedCrypt’s FDA expert, Naomi Schwartz. https://t.co/nDz8MYelea #RefuseToAccept

In a new article posted to Forbes, Medcrypt CEO Mike Kijewski discusses how healthtech companies can best prepare for the FDA’s impending RTA guidelines — as well as the importance of cybersecurity to the industry. Read Mike’s full article on Forbes here:

Trying to get your manually created or auto-generated SBOMs into a standardized tool and format? Helm can help! Learn more about how Helm can improve your medical device vulnerability management: https://t.co/ym2nNvGXRx

On March 8th, MedCrypt's Axel Wirth and Naomi Schwartz discussed the regulatory implications of President Biden's newly signed omnibus bill on the medical device manufacturing industry. Missed this webinar? Watch the full recording here: https://t.co/EIdsRpEL2s